Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.82 CAD | +0.87% | +2.28% | +12.14% |
03-22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
03-21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.14% | 430M | |
+6.14% | 69.91B | |
+12.55% | 9.24B | |
-12.75% | 5.05B | |
+42.38% | 4.47B | |
+5.23% | 3.92B | |
+23.71% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Brief: Enters into Exclusive Supply and Distribution Agreement with NASDAQ's Incyte for Tafasitamab and Pemigatinib in Latin America